ethyl 1-allyl-4,5-dioxopyrrolidine-3-carboxylate | 67044-07-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯烷类
• 英文名称: ethyl 1-allyl-4,5-dioxopyrrolidine-3-carboxylate
• 英文别名: Ethyl 4,5-dioxo-1-prop-2-enylpyrrolidine-3-carboxylate
• CAS: 67044-07-9
• 化学式: C₁₀H₁₃NO₄
• 分子量: 211.218
• InChiKey: XXOCIOQRSNSUQA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  15
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  63.7
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  ethyl 1-allyl-4,5-dioxopyrrolidine-3-carboxylate 在 盐酸 、 原乙酸三甲酯 、 三甲基氯硅烷 、 AD-mix-β 、 水 、 对甲苯磺酸 作用下， 以 甲醇 、 二氯甲烷 、 水 、 甲苯 、 叔丁醇 为溶剂， 反应 49.0h， 生成 2-[2-hydroxy-3-(4-phenylpiperazin-1-yl)propyl]-1,2-dihydropyrrolo[3,4-b]quinolin-3-one
  参考文献：
  名称：

  Chemoenzymatic synthesis with lipase catalyzed resolution and evaluation of antitumor activity of (R/S)-2-[2-hydroxy-3-(4-phenylpiperazin-1-yl)propyl]-1H-pyrrolo[3,4-b]quinolin-3(2H)-one

  摘要：

  Synthesis, characterization, resolution and evaluation of novel (R/S)-2-[2-hydroxy-3-(4-phenylpiperazin-1-yl)propyl]-1H-pyrrolo[3,4-b]quinolin-3(2H)-one derivatives are described. Enantiomerically pure compounds were isolated in good to excellent yield with high enantiomeric excess under mild reaction conditions by using Candida antarctica B (CAL-B) and Candida rugosa (CRL) Lipases. Newly synthesized and resolved compounds were screened for their antitumor activity against cancer cells such as human neuroblastoma SK-N-SH and human lung carcinoma A549 cell line in vitro. The results have shown that the compound 1 S-(-) alcohol was more effective in inhibiting the tumor cell growth. (C) 2011 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2011.02.069
• 作为产物：
  描述：

  3-(烯丙基氨基)丙酸乙酯 以76%的产率得到
  参考文献：
  名称：

  SATO YASUNOBU; SHIMOJI YASUO; FUJITA HIROSHI; MIZUNO HIROSHI; KUMAKURA SE+, YAKUGAKU DZASSI, JAKUGAKU ZASSNI, J. PHARM. SOS. JAR., 1978, 98, NO 4, 44+

  摘要：

  DOI：

文献信息

• [EN] SMALL MOLECULE INHIBITORS OF NF-kB INDUCING KINASE<br/>[FR] INHIBITEURS À PETITE MOLÉCULE DE KINASE INDUISANT NF-KB
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2020239999A1

  公开（公告）日：2020-12-03

  The present invention relates to compounds that inhibit NIK and pharmaceutical compositions comprising such compounds and methods of using the same. These compounds and pharmaceutical compositions are envisaged to be useful for preventing or treating diseases such as cancer (such as B-cell malignancies including leukemias, lymphomas and myeloma), inflammatory disorders, autoimmune disorders, immunodermatologic disorders such as palmoplantar pustulosis and hidradenitis suppurativa, and metabolic disorders such as obesity and diabetes.

  本发明涉及抑制NIK的化合物，以及包含这些化合物的药物组合物和使用方法。这些化合物和药物组合物预期能用于预防或治疗癌症（如包括白血病、淋巴瘤和多发性骨髓瘤的B细胞恶性肿瘤）、炎症性疾病、自身免疫疾病、免疫皮肤病学疾病（如掌跖脓疱病和化脓性汗腺炎）以及代谢紊乱疾病（如肥胖和糖尿病）。
• Small molecule inhibitors of NF-κB inducing kinase
  申请人：Janssen Pharmaceutica NV

  公开号：US11254673B2

  公开（公告）日：2022-02-22

  The present invention relates to compounds that inhibit NIK and pharmaceutical compositions comprising such compounds and methods of using the same. These compounds and pharmaceutical compositions are envisaged to be useful for preventing or treating diseases such as cancer (such as B-cell malignancies including leukemias, lymphomas and myeloma), inflammatory disorders, autoimmune disorders, immunodermatologic disorders such as palmoplantar pustulosis and hidradenitis suppurativa, and metabolic disorders such as obesity and diabetes.

  本发明涉及抑制 NIK 的化合物、含有此类化合物的药物组合物以及使用方法。根据设想，这些化合物和药物组合物可用于预防或治疗癌症（如 B 细胞恶性肿瘤，包括白血病、淋巴瘤和骨髓瘤）、炎症性疾病、自身免疫性疾病、免疫性皮肤病（如掌跖脓疱病和化脓性扁桃体炎）以及代谢性疾病（如肥胖症和糖尿病）等疾病。
• Lewis acid-assisted olefin cross-metathesis reaction: an efficient approach for the synthesis of glycosidic-pyrroloquinolinone based novel building blocks of camptothecin and evaluation of their antitumor activity
  作者：Lingaiah Nagarapu、Hanmant K. Gaikwad、Rajashaker Bantu、Sheeba Rani Manikonda、C. Ganesh Kumar、Sujitha Pombala

  DOI：10.1016/j.tetlet.2012.01.001

  日期：2012.3

  A series of glycosidic-pyrroloquinolinone based novel building blocks of camptothecin (2a-g) were synthesized via Lewis acid-assisted olefin cross-metathesis reaction using Ti((OPr)-Pr-i)(4) 30 mol % and 10 mol % of Grubb's second generation catalyst with good to excellent yields. Most of these compounds exhibited significant growth inhibitory effects on all the tested cancer cell lines and three compounds (2c, 2d and ze) showed potent cytotoxic activity. (C) 2012 Elsevier Ltd. All rights reserved.
• A new synthesis of the cytotoxic alkaloid Luotonine A
  作者：Sabrina Dallavalle、Lucio Merlini

  DOI：10.1016/s0040-4039(02)00140-5

  日期：2002.3

  A convenient synthesis of the cytotoxic alkaloid Luotonine A has been achieved using cheap and readily accessible reagents. The key intermediate in the synthesis is the tricyclic Compound 2,3-dihydro[1H]-pyrrolo[3,4-b]quinolin-3-one (5). (C) 2002 Elsevier Science Ltd. All rights reserved.
• Discovery of tetrahydrofuranyl spirooxindole-based SMYD3 inhibitors against gastric cancer via inducing lethal autophagy
  作者：Hong-Ping Zhu、Jinlong Chai、Rui Qin、Hai-Jun Leng、Xiang Wen、Cheng Peng、Gu He、Bo Han

  DOI：10.1016/j.ejmech.2022.115009

  日期：2023.1